Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.56 |
| ▸ | MAT2A | P31153 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 3/20 | 0.40 |
| ▸ | RORA | P35398 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
| ▸ | RORB | Q92753 | 1/20 | 0.37 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.37 |
| ▸ | PGR | P06401 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | MIF | P14174 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9916263 | 0.97 | KDM4E (0.60) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL16202906 | 0.93 | KDM4E (0.51) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL20647203 | 0.92 | MAT2A (0.50) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL1102407 | 0.90 | KDM4E (0.60) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL22260172 | 0.86 | KDM4E (0.55) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL23776251 | 0.86 | MAT2A (0.47) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL19342645 | 0.86 | KDM4E (0.48) | KDM4EATML3MBTL1KIF11PTPN1 | |
| SCHEMBL26496209 | 0.85 | ATM (0.46) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL26180242 | 0.85 | PPARG (0.44) | KDM4EATML3MBTL1MAT2AKIF11 | |
| SCHEMBL13522722 | 0.85 | KDM4E (0.50) | KDM4EATML3MBTL1MAT2AKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8153279-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2012-04-10 | — | — | US | disclosed |
| US-7906228-B2 | Compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2011-03-15 | — | — | US | disclosed |
| US-7888863-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2011-02-15 | — | — | US | disclosed |
| US-7888863-B2 | Organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2011-02-15 | — | — | US | disclosed |
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-04-22 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-04 | — | — | US | disclosed |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-25 | — | — | US | disclosed |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-26 | — | — | US | disclosed |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-11-05 | — | — | US | disclosed |
| US-20090260686-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
| US-20090260686-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2009-10-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090260686-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, FZD7 | KDM4E 3940/4885ATM 4499/4885L3MBTL1 1237/4885 |
| US-20100096982-A1 | Novel organic electroluminescent compounds and organic electrouminescent device using the same | OCIAD1, OR10J3, ORMDL3 | KDM4E 4170/4885ATM 4848/4885L3MBTL1 479/4885 |
| US-20100045170-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | KDM4E 3671/4885ATM 4820/4885L3MBTL1 1193/4885 |
| US-20090273277-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, ORMDL3, CHRM2 | KDM4E 3872/4885ATM 4684/4885L3MBTL1 283/4885 |
| US-20100051106-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | RPL36, RPL39, RPL36A | KDM4E 4138/4885ATM 4252/4885L3MBTL1 1117/4885 |
| US-20090273278-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | KDM4E 3298/4885ATM 4850/4885L3MBTL1 1573/4885 |
| US-20100033083-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | ORMDL3, OCIAD2, OCIAD1 | KDM4E 3367/4885ATM 4432/4885L3MBTL1 1629/4885 |
| US-20090288707-A1 | Novel compounds for electronic material and organic electronic device using the same | OCIAD1, OCIAD2, ORMDL3 | KDM4E 3509/4885ATM 4102/4885L3MBTL1 1888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.